INSIGHTS ON CELL & GENE OUTSOURCING ISSUES

• Improving Viral Vector Production Through Addressing Complexity

  In a recent webinar, Novartis Contract Manufacturing experts explored innovations in viral vector manufacturing and addressed production challenges and quality control strategies.

• Developing Scalable, Global Solutions For Cell & Gene Manufacturing

  Cell and gene therapies offer transformative potential for treating complex diseases, but their manufacturing and global delivery face significant challenges.

• Phase-Appropriate Approaches To Manufacturing And Testing

  Accelerate the development of high-quality biopharmaceuticals by implementing phase-appropriate, risk-based manufacturing and testing strategies that ensure timely progression.

• Analytical Method Release And Stability Platform For RNA Drug Substance

  We offer comprehensive analytical support across the R&D space, including method development, validation, process characterization, in-process testing, process validation, and GMP release testing.

• Arcellx On Designing A Dynamic CAR-T

  Arcellx's CMO and CTO talk about the company's platform technology, its partnership with Kite, and preparing its lead asset, anito-cel, for commercial launch.

• Advancing Innovative Plasmid DNA Manufacturing Solutions For CGT

  Having produced over 185,000 DNA lots, including 5,000+ cGMP batches, we are a trusted partner in plasmid DNA production from discovery to commercialization.

• Are CDMO Partnerships The Answer To Manufacturing Capacity Issues?

  The current manufacturing strain is exacerbated by factors such as the intensity of scaling up fill-finish and specialized manufacture of drug delivery devices. How can partnering with a CDMO help?

• Future-Proofing Life Sciences Manufacturing: 2025 CDMO Trends

  Explore the evolution of the life sciences contract manufacturing sector, driven by technological advancements and regulatory changes, as well as learn how CMOs and CDMOs are navigating opportunities and challenges.

• With Passion We Bring Pharmaceutical Solutions To Life

  By combining technical excellence with a passion for progress, we enable our customers to bring life-changing therapies to market efficiently and reliably.

• Our Analytical And Quality Control Strategy For Your Therapies

  A comprehensive Quality Risk Analysis and Control Strategy is built on five key pillars, each playing a vital role in ensuring that every final product meets the highest safety and efficacy standards.